Recent Posts
- And that’s a wrap 2023! Christmas with IR Department
- This is what the ASX and investors expect for gender diversity on your board
- 5 key lessons any company can take away from our foundational ESG report
- What small caps can take away from Amazon’s move to write emissions data into its supplier standards
- How Australian small caps are likely to be impacted by the new ISSB sustainability disclosure standards
Archives
Innovating sleep apnoea care
Sleep apnoea is a potentially serious condition but only one in five patients are in care.
Oventus (ASX:OVN) is innovating sleep apnoea care with its patented airway design that creates a 'second nose'. Using CAD software to create a 3D drawing of the patient’s mouth and bite, Oventus uses 3D printing technology to manufacture these custom-made medical-grade mouthguards from titanium.
April 2nd, 2018
by
IR Dept
Read More
- 1